Mechanisms of receptor tyrosine kinase activation in cancerZhenfang Du, Christine M. Lovly|Molecular Cancer|2018Cited by 1.1k
Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targetingZhenfang Du, Christine M. Lovly|Nature Communications|2021Cited by 70
The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylationZhenfang Du, Qian Tao|Oncotarget|2016Cited by 28